Scott B. Ullem sold $852k of EW
CVP, Chief Financial Officer at Edwards Lifesciences Corp. 11,250 shares at an average of $75.76, traded Feb 13, 2025, filed Feb 13, 2025.
Score components
- +22RoleCFO
- +23Trade size$852k at market
- +10Share of holdings soldSold 27% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001225208-25-001712, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 13, 2025 | MOption exercise Common Stock10b5-1 | +11,250 | $45.28 | $509k | 41,811 | Feb 13, 2025 |
| Feb 13, 2025 | SOpen-market sale Common Stock10b5-1 | -11,250 | $75.76 | $852k | 30,561 | Feb 13, 2025 |
| Feb 13, 2025 | MOption exercise Employee Stock Option (Right to Acquire)derivative10b5-1 | -11,250 | $0.00 | $0 | 33,750 | Feb 13, 2025 |
Related signals
Other insiders at Edwards Lifesciences Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Edwards Lifesciences Corp | Daniel J. Lippis CVP, TAVR | $53k 619 shares | -2% | |
| 0Weak | Edwards Lifesciences Corp | Daniel J. Lippis CVP, TAVR | $54k 619 shares | -2% | |
| 15Weak | Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $974k 11,340 shares | -35% | |
| 60Notable | EWsell Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $2.0M 24,000 shares | -53% | |
| 15Weak | Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $971k 11,340 shares | -26% | |
| 59Moderate | Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $954k 11,386 shares | -23% | |
| 42Moderate | Edwards Lifesciences Corp | Heisz Leslie Stone director | $218k 2,615 shares | -8% | |
| 4Weak | Edwards Lifesciences Corp | Daniel J. Lippis CVP, JAPAC | $86k 1,019 shares | -4% | |
| 41Moderate | Edwards Lifesciences Corp | Daveen Chopra CVP, TMTT & Surgical | $169k 2,000 shares | -6% | |
| 24Weak | Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $951k 11,340 shares | -18% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.